)
Sanket Koul is a mass communication graduate with a PG diploma in English Journalism from IIMC Delhi. As a correspondent at Business Standard, he covers the pulse of the social sector, from industry and institutional developments, to the government's latest moves in education, healthcare, pharmaceuticals and medical devices sectors.
Sanket Koul is a mass communication graduate with a PG diploma in English Journalism from IIMC Delhi. As a correspondent at Business Standard, he covers the pulse of the social sector, from industry and institutional developments, to the government's latest moves in education, healthcare, pharmaceuticals and medical devices sectors.
Mankind Pharma has received CDSCO approval to initiate Phase 1 trials of MKP11093, a novel JAK-1 inhibitor for autoimmune disorders, as part of its expanding R&D pipeline
The land parcel has a group housing development potential of 1.3 mn square feet, and will complement its Estate 360 project located on Dwarka Expressway in Sector 36A
UDISE+ 2024-25 shows India's teaching workforce crossed 10 million with women forming 54.2 per cent, even as enrolments fell to 246.95 million due to lower primary share
Rising elderly population, policy push and investor interest to drive demand
AIMED said GST changes could hurt domestic medtech competitiveness and tilt the market towards imports, urging balanced tax slabs, refund reforms, and a higher Health Cess
Says sector fortified with sound financial position, diversified biz model
Akums will hold 51% in its joint venture with the Zambian government to set up a pharma manufacturing facility, marking its first overseas plant and Africa expansion
Hospital body issues notice to Care Health Insurance; says low rates, heavy deductions behind move
CRE Matrix denies the allegations of data theft, calling them unfounded, while PropEquity moves the Delhi High Court seeking damages and an injunction
CDSCO flagged eight spurious drugs and 134 substandard formulations in July 2025, while Novo Nordisk reported theft of insulin and Wegovy batches during transit in India
British businessman Sukhpal Ahluwalia has purchased an 11,416 sq ft apartment at DLF's luxury project The Camellias in Gurugram for Rs 100 crore, underscoring demand for high-end homes
Fortis Healthcare has partnered with Ekana Group to manage a 550-bed greenfield hospital in Lucknow, expanding its Uttar Pradesh presence alongside its Noida and Greater Noida units
PropEquity has moved the Delhi High Court against CRE Matrix alleging data theft, seeking damages of Rs 8 crore as the court issues summons and sets next hearing for September 19
Landmark Group has announced a Rs 400 crore investment in the second phase of its luxury housing project SKYVUE in Gurugram, featuring premium towers with high-end amenities
Hospitality majors like IHCL, Marriott, and others are partnering with developers to tap the growing demand for branded residences, as luxury homebuyers drive the trend across metro and tier-II cities
A high-level inter-departmental committee has begun discussions on regulating refurbished medical devices, balancing patient safety concerns with affordable healthcare access
Nathealth urges the government to cap GST input slabs for healthcare at 5% and allow input credits, citing rising embedded taxes that increase costs for providers and patients
The Bill grants IIM Guwahati a Rs 555 crore fund for five years, making it the second IIM in the Northeast after Shillong, with a permanent campus to come up near Guwahati
Real estate developers and consultants say UER-II and the Dwarka Expressway will improve connectivity, ease congestion, and drive housing and commercial growth in Delhi NCR
Drugmakers aim to step up production by 15-20% in the near term